基于TNM分期的腹腔镜与开腹远端胃切除术治疗局部进展期胃癌的成本效果分析:Markov模型
本研究基于CLASS-01试验数据构建Markov模型,从中国社会角度评估腹腔镜远端胃切除术(LDG)与开腹远端胃切除术(ODG)治疗不同分期局部进展期胃癌的长期成本效果。结果显示,在I期患者中LDG可能具有成本效果,而在II期和III期患者中ODG更具成本效果优势。敏感性分析表明基础-case结果对参数不确定性稳健。
要点
- I期患者中LDG的ICER为2829.98美元/QALY,低于支付意愿阈值,可能具有成本效果。
- II期和III期患者中ODG的QALY增益更高,ICER为负值,提示ODG更具成本效果。
- 敏感性分析显示基础-case结果对参数不确定性稳健。
核心结论
- 基于模型假设和参数,模拟结果显示LDG在I期患者中可能具有成本效果,而ODG在II期和III期患者中更具优势。
研究设计与样本
- 基于CLASS-01试验数据构建Markov模型,包含稳定疾病、疾病进展和死亡三个健康状态,从中国社会角度进行评估。
主要发现
- I期患者中,LDG提供0.29个增量QALY,增量成本为819.33美元,ICER为2829.98美元/QALY,低于支付意愿阈值。
- II期患者中,ODG的增量QALY为-0.14(即LDG更少),增量成本为1073.62美元,ICER为-7692.45美元/QALY。
- III期患者中,ODG的增量QALY为-0.22,增量成本为913.41美元,ICER为-4232美元/QALY。
临床怎么用
- 对于I期局部进展期胃癌患者,LDG可能是一种具有成本效果的策略。
- 对于II期和III期局部进展期胃癌患者,ODG可能更具成本效果优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although laparoscopic distal gastrectomy (LDG) and open distal gastrectomy (ODG) show comparable short- and long-term efficacy for treating locally advanced gastric cancer (LAGC), evidence on the cost-effectiveness of LDG versus ODG remains limited. This study aimed to evaluate the long-term cost-effectiveness of LDG versus ODG in patients with LAGC at different stages from a societal perspective in China. METHODS: A Markov model incorporating three health states (stable disease, disease progression, and death) was constructed based on data from the CLASS-01 trial. The outcome measures included incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs). Cost-effectiveness was assessed by comparing the ICER to the willingness-to-pay (WTP) threshold. Sensitivity analyses were conducted to evaluate model uncertainty. RESULTS: In stage I patients, the model projected that LDG provided 0.29 incremental QALYs at an incremental cost of $819.33, yielding an ICER of $2829.98/QALY-below the WTP threshold, indicating potential cost-effectiveness conditional on the model parameters. Conversely, in stage II and III patients, ODG was associated with higher QALY gains than LDG (simulated incremental QALYs of - 0.14 and - 0.22, respectively), and the ICERs were negative (stage II: ICER - $7692.45 per QALY, incremental cost $1073.62; stage III: ICER - $4232 per QALY, incremental cost $913.41), suggesting that ODG was the cost-effective strategy within the simulation framework. Sensitivity analyses indicated that base-case findings were robust to parameter uncertainty. CONCLUSION: Based on the model's assumptions and parameterization, the simulated results indicate that LDG is likely cost-effective in stage I patients, while ODG appears more advantageous in stage II and III patients.
引用
- Lai M, Qin Q, Li Y, et al. Cost-effectiveness analysis of laparoscopic versus open distal gastrectomy for locally advanced gastric cancer based on TNM stage: a Markov model. Surg Endosc. 2026. PMID: 41792488. doi:10.1007/s00464-026-12707-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。